Fatal rhabdomyolysis caused by lipid-lowering therapy.

Southern medical journal

Volumn 94, Issue 10, 2001, Pages 1023-1026

  Federman, D G ^a   Hussain, F ^a   Walters, A B ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; FATALITY; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PATHOPHYSIOLOGY; RHABDOMYOLYSIS;

AGED; ANTILIPEMIC AGENTS; DRUG INTERACTIONS; FATAL OUTCOME; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; RHABDOMYOLYSIS; SIMVASTATIN;

MLCS; MLOWN;

EID: 0035487535     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200110000-00016     Document Type: Article

References (0)